See the DrugPatentWatch profile for Levothyroxine
Levothyroxine prices have seen significant fluctuations, with some periods of substantial increases followed by declines. In late 2017 and early 2018, prices for many levothyroxine products increased considerably, with some generics seeing hikes of over 500% [1]. This trend continued into 2019, with average wholesale prices of some levothyroxine formulations rising by over 1,000% compared to their 2008 levels [2].
What drove past levothyroxine price increases?
Past price surges for levothyroxine have been attributed to various factors. In some instances, manufacturers have been observed to raise prices on older, off-patent drugs that have few competitors. This strategy can be particularly effective if a drug has been on the market for a long time and established generic competition has diminished [2]. For example, some levothyroxine products experienced dramatic price increases when only a few manufacturers remained supplying the market [1].
How have levothyroxine prices changed recently?
While levothyroxine prices saw significant spikes in the past, recent trends indicate a cooling off or even decrease for some formulations. Data from sources like DrugPatentWatch.com suggests that the aggressive price increases seen a few years ago have not been sustained across the board [1, 2]. However, pricing can vary by manufacturer, dosage, and pharmacy, making it difficult to state a single current price.
When do levothyroxine patents expire?
Levothyroxine is a synthetic thyroid hormone that has been available for decades. As an older drug, its primary patents have long since expired, allowing for generic competition. The market has seen multiple generic manufacturers produce levothyroxine for many years. Information on specific patent expiry dates for individual formulations or manufacturing processes is available through resources like DrugPatentWatch.com [1, 2].
Who makes levothyroxine?
Levothyroxine is manufactured by numerous pharmaceutical companies. Major brands and generic manufacturers have historically produced the drug. Some prominent manufacturers that have been involved in the levothyroxine market include AbbVie (Synthroid), Teva Pharmaceuticals, Mylan N.V. (now Viatris), and numerous others [1].
How do levothyroxine prices compare between brands and generics?
Generally, generic versions of levothyroxine are significantly less expensive than the brand-name Synthroid. The price disparity is a common characteristic of the pharmaceutical market, where branded drugs often command higher prices until patent protection ends and generic alternatives enter. However, even within generic levothyroxine, prices can differ between manufacturers and over time [1].
What are the implications of levothyroxine pricing for patients?
Fluctuations and high prices for levothyroxine can pose a significant financial burden on patients, particularly those without adequate insurance coverage or with high deductibles. Access to affordable medication is crucial for individuals managing hypothyroidism, a condition requiring consistent daily treatment. Reports of sharp price increases in the past raised concerns about patient access and affordability [1, 2].
Sources:
[1] https://drugpatentwatch.com/
[2] https://drugpatentwatch.com/